
Inhibition and stimulation of activity of purified recombinant CYP11A1 by therapeutic agents
Keywords: Adx; adrenodoxin; Adr; adrenodoxin reductase; DLPC; dilauroylglycerol-3-phosphatidylcholine; HPCD; 2-hydroxypropyl-β-cyclodextrin; KPi; potassium phosphate; PL; phospholipid; Cytochrome P450; CYP11A1; CYP46A1; Inhibition; Activation; Drug target;